Differences in Hemoglobin Levels in Patients with Thalassemia Major and Minor at Sultan Agung Semarang Islamic Hospital

Sri Mayang Sari; Ragil Saptaningtyas; Gela Setya Ayu Putri; Andri Sukeksi

Authors

Sri Mayang Sari Universitas Muhammadiyah Semarang
Ragil Saptaningtyas Universitas Muhammadiyah Semarang
Gela Setya Ayu Putri Universitas Muhammadiyah Semarang
Andri Sukeksi Universitas Muhammadiyah Semarang

Keywords:

hemoglobin, thalassemia mayor, thalassemia minor

Abstract

Background: One of the genetic diseases that is usually detected in children is thalassemia. World Health Organization (WHO) states that thalassemia is the most common hereditary disease in the world and has been recognized as a world health problem. Indonesia is one of the countries in the world's thalassemia belt. Thalassemia major is the most severe clinical condition of thalassemia. Thalassemia minor can also be called a carrier trait and does not show clinical symptoms. Supporting examinations can be carried out with simple laboratory tests, one of which is measuring hemoglobin levels. This study aimed to determine the differences in hemoglobin levels in patients with thalassemia major and thalassemia minor at RSI Sultan Agung Semarang. Method: The type of research used was cross-sectional, with a sample size of 48 people. Hemoglobin level data was obtained from the medical records of Sultan Agung Semarang Islamic Hospital. The data distribution is normal, so the difference test is tested using the independent t-test. Result: The average hemoglobin levels in patients with thalassemia major and thalassemia minor are 5.7 mg/dL and 10.6 mg/dL. The independent t-test shows a significance value of 0.00 (<0.05). Conclusion: There are differences in hemoglobin levels in thalassemia major and thalassemia minor patients at Sultan Agung Semarang Islamic Hospital, although hemoglobin levels in both thalassemia major and minor patients are still below the reference value.

Author Biographies

Sri Mayang Sari, Universitas Muhammadiyah Semarang

First author

Ragil Saptaningtyas, Universitas Muhammadiyah Semarang

Corresponding author

References

. Thalassaemia International Federation, ‘Thalassaemia International Federation. Guidelines for the Management of Transfusion Dependent Thalassemia (TDT).’, HemaSphere, vol. 6, no. 8, 2022, doi: http://dx.doi.org/10.1097/HS9.0000000000000732.

. M. K. R. Indonesia, ‘Keputusan Menteri Kesehatan Republik Indonesia Nomor Hk.01.07/Menkes/1/2018 Tentang Pedoman Nasional Pelayanan Kedokteran Tata Laksana Thalasemia’, 2018.

. WHO, Regional Desk Review of Haemoglobinopathies with an Emphasis on Thalassaemia and Accessibility and Availability of Safe Blood and Blood Products as per These Patients’ Requirement in South-East Asia Under Universal Health Coverage. 2021.

. J. Old, ‘Thalassaemias and Other Haemoglobinopathies’, Genet. Disord. Indian Subcont., no. May, pp. 245–264, 2004, doi: 10.1007/978-1-4020-2231-9_13.

. Rujito L., Buku Referensi Talasemia : Genetik Dasar dan Pengelolaan Terkini. 1st ed. Purwokerto: Universitas Jenderal Soedirman, no. November 2019. 2019.

. Thalassemia International Federation, Guidelines for the Management of Non Transfusion Dependent Thalassaemia (Ntdt) 2 Nd Edition Editors of the 1 St Edition Ali Taher Elliott Vichinsky Khaled Musallam Maria Domenica Cappellini Vip Viprakasit Editors of the 2 Nd Edition Ali Taher Khaled Musal, no. 22. 2017.

. V. Viprakasit and S. Ekwattanakit, ‘Clinical Classification, Screening and Diagnosis for Thalassemia.’, Hematol. Oncol. Clin. North Am., vol. 32, no. 2, pp. 193–211, Apr. 2018, doi: 10.1016/j.hoc.2017.11.006.

. G. P. Rodgers, Bethesda Handbook of Clinical Hematology. Lippincott Williams & Wilkins, 2013.

. D. P. Hoffbrand, A Victor, Higgs, Steensma, Hoffbrand’s Essential Haematology. Wiley Blackwell, 2020.

. E. P. Vichinsky, ‘Changing patterns of thalassemia worldwide’, Ann. N. Y. Acad. Sci., vol. 1054, no. October, pp. 18–24, 2005, doi: 10.1196/annals.1345.003.

. Y. K. Lee et al., ‘Recent progress in laboratory diagnosis of thalassemia and hemoglobinopathy: A study by the Korean Red Blood Cell Disorder Working Party of the Korean Society of Hematology’, Blood Res., vol. 54, no. 1, pp. 17–22, 2019, doi: 10.5045/br.2019.54.1.17.

. N. R. Sausan, Asuhan Keperawatan Pada Klien Anak Dengan Thalasemia Yang Di Rawat Di Rumah Sakit. 2020.

. T. H. Jaing, T. Y. Chang, S. H. Chen, C. W. Lin, Y. C. Wen, and C. C. Chiu, ‘Molecular genetics of β-thalassemia: A narrative review’, Med. (United States), vol. 100, no. 45, p. E27522, 2021, doi: 10.1097/MD.0000000000027522.

. H. Nomani et al., ‘Atrial fibrillation in β-thalassemia patients with a focus on the role of iron-overload and oxidative stress: A review.’, J. Cell. Physiol., vol. 234, no. 8, pp. 12249–12266, Aug. 2019, doi: 10.1002/jcp.27968.

. Y. Farid and P. Lecat, ‘Biochemistry, Hemoglobin Synthesis’, StatPearls, pp. 1–5, 2019, [Online]. Available: http://www.ncbi.nlm.nih.gov/pubmed/30725597.

. D. . Mahardika and Astuti Tri.D, ‘Systematic Review: Analisis Kadar Hemoglobin Pada Kasus Talasemia Β Naskah Publikasi’, Progr. Stud. Teknol. Lab. Medis Fak. Ilmu Kesehat. Univ. ’Aisyiyah Yogyakarta, pp. 1–10, 2020.